• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Saturday, January 23, 2021
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Building a 3D model of ovarian cancer

Bioengineer by Bioengineer
March 2, 2014
in Cancer
1
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The European Research Council (ERC) has awarded researchers at Barts Cancer Institute, Queen Mary University of London, a €2.43million grant for a project that aims to revolutionise the field of cancer cell research: using bioengineering techniques to grow the first complex 3D human tumour in the laboratory

Building a 3D model of ovarian cancer

Human cancers are more than just malignant cells, even at their very beginning. Other cells and chemicals that normally support and protect the body are hijacked by the cancer cells, instead helping the cancer to grow and spread.

Recent research has shown us the importance of targeting not only the malignant cancer cells but also this wider tumour microenvironment for long-term cancer treatment.

In the CANBUILD project, the multi-disciplinary team of scientists will be using the latest advances in tissue engineering, biomechanics, imaging and stem cell biology. They believe this combination will make it possible to engineer, for the first time, a complex 3D human tumour in which the different cell types making up the tumour microenvironment could communicate, evolve and grow in vitro (outside the body, in the laboratory).

The CANBUILD goal is to recreate the tumour microenvironment found in high-grade human ovarian cancer; the subtype that leads to 70 per cent of all ovarian cancer deaths. However, the research may have implications for several other cancer types as well.

The vision is that this project will replace traditional techniques in which human cancer cells are grown in isolation on plastic surfaces. Success in the CANBUILD project may also provide better ways of testing new drugs that target the human tumour microenvironment.

Professor Fran Balkwill, from Barts Cancer Institute, is Principal Investigator on the CANBUILD project. Professor Balkwill said:

“About half the cells in a tumour are not cancer cells, but ‘healthy’ cells such as immune cells and fibroblasts, which the cancer is somehow corrupting to help it grow and spread.

“It seems logical that the best long-term treatments will come from combining both therapies that target the cancer cells with something aimed at the wider tumour microenvironment which, while not cancerous cells themselves, are supporting the cancer’s growth.

“Growing an in vitro model, which contains all these types of cells, will allow us to watch how the cells communicate and how the tumour grows, teaching us more about what is going on in this complex system and hopefully giving us a model we can test new drugs on.”

The five-year research plan involves:

  • ‘Deconstruction’ of the human ovarian cancer tumour microenvironment
  • Constructing the artificial scaffold, optimising growth of different cell types, and assembling the model
  • Comparing the model to fresh human tissue
  • Investigating the roles of individual cells
  • Testing new treatments that target the tumour microenvironment
  • The ERC funding will also allow the team to communicate their research via the Centre of the Cell, Queen Mary’s award-winning science education centre and online resource, widening participation and outreach.

    Story Source:

    The above story is based on materials provided by Barts Cancer Institute.

    Share12Tweet8Share2ShareShareShare2

    Related Posts

    IMAGE

    University of Cincinnati research unveils possible new combo therapy for head and neck cancer

    January 22, 2021
    IMAGE

    CT identifies patients with high-risk nonalcoholic fatty liver disease (NAFLD)

    January 22, 2021

    New combination of immunotherapies shows great promise for treating lung cancer

    January 22, 2021

    Catching cancer in the act

    January 21, 2021
    Next Post
    blank

    World's First 'Bionic' Dog

    blank

    Think Like a Proton & Stay Positive

    Leave a Reply Cancel reply

    Your email address will not be published.

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    POPULAR NEWS

    • IMAGE

      The map of nuclear deformation takes the form of a mountain landscape

      54 shares
      Share 22 Tweet 14
    • People living with HIV face premature heart disease and barriers to care

      65 shares
      Share 26 Tweet 16
    • New drug form may help treat osteoporosis, calcium-related disorders

      40 shares
      Share 16 Tweet 10
    • New findings help explain how COVID-19 overpowers the immune system

      35 shares
      Share 14 Tweet 9

    About

    We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

    Follow us

    Tags

    Technology/Engineering/Computer ScienceBiologyClimate ChangePublic HealthMaterialsInfectious/Emerging DiseasesMedicine/HealthcancerGeneticsCell BiologyEcology/EnvironmentChemistry/Physics/Materials Sciences

    Recent Posts

    • Regulating the ribosomal RNA production line
    • A professor from RUDN University developed new liquid crystals
    • New technique builds super-hard metals from nanoparticles
    • No more needles for diagnostic tests?
    • Contact Us

    © 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

    No Result
    View All Result
    • Homepages
      • Home Page 1
      • Home Page 2
    • News
    • National
    • Business
    • Health
    • Lifestyle
    • Science

    © 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

    Welcome Back!

    Login to your account below

    Forgotten Password?

    Create New Account!

    Fill the forms below to register

    All fields are required. Log In

    Retrieve your password

    Please enter your username or email address to reset your password.

    Log In